JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GRID
5851
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12.2B
| $10.2K | ﹤0.01% |
+104
| New | +$9.77K |
2023 Q1
0 quarters
|
|
|
BCLI
5852
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $10K | ﹤0.01% |
+199
| New | +$5.77K |
2023 Q1
0 quarters
|
|
5853
Celcuity
CELC
$3.61B
| $10K | ﹤0.01% |
982
-3,988
| -80% | -$43.7K |
2022 Q4
1 quarter
|
|
5854
Dare Bioscience
DARE
$16.5M
| $10K | ﹤0.01% |
+780
| New | +$10.4K |
2023 Q1
0 quarters
|
|
5855
Delcath Systems
DCTH
$549M
| $10K | ﹤0.01% |
+1,805
| New | +$8.02K |
2023 Q1
0 quarters
|
|
5856
VanEck Emerging Markets High Yield Bond ETF
HYEM
$508M
| $10K | ﹤0.01% |
555
-2,725
| -83% | -$50.6K |
2020 Q1
12 quarters
|
|
5857
VanEck International High Yield Bond ETF
IHY
$39.4M
| $10K | ﹤0.01% |
+481
| New | +$9.66K |
2023 Q1
0 quarters
|
|
5858
Immuneering
IMRX
$264M
| $10K | ﹤0.01% |
1,030
+70
| +7% | +$397 |
2021 Q3
6 quarters
|
|
5859
Rekor Systems
REKR
$50.3M
| $10K | ﹤0.01% |
8,077
| – | – |
2021 Q2
7 quarters
|
|
|
SCD
5860
LMP Capital and Income Fund
SCD
$337M
| $10K | ﹤0.01% |
+809
| New | +$9.94K |
2023 Q1
0 quarters
|
|
5861
Smart Sand
SND
$227M
| $10K | ﹤0.01% |
5,940
+5,299
| +827% | +$9.86K |
2017 Q4
21 quarters
|
|
5862
Tenon Medical
TNON
$2.49M
| $10K | ﹤0.01% |
2
| – | – |
2022 Q2
3 quarters
|
|
|
OMGA
5863
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $10K | ﹤0.01% |
1,684
+128
| +8% | +$891 |
2021 Q3
6 quarters
|
|
|
SLGCW
5864
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| – | – |
0
| – | – |
2021 Q3
6 quarters
|
|
5865
NYLIM Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
| $9.81K | ﹤0.01% |
336
-22,799
| -99% | -$662K |
2022 Q4
1 quarter
|
|
5866
Overlay Shares Hedged Large Cap Equity ETF
OVLH
$109M
| $9.76K | ﹤0.01% |
+377
| New | +$9.61K |
2023 Q1
0 quarters
|
|
5867
Franklin FTSE United Kingdom ETF
FLGB
$848M
| $9.66K | ﹤0.01% |
+399
| New | +$9.59K |
2023 Q1
0 quarters
|
|
5868
iShares Global Materials ETF
MXI
$436M
| $9.34K | ﹤0.01% |
109
+58
| +114% | +$4.83K |
2021 Q2
7 quarters
|
|
5869
Pacer Trendpilot 100 ETF
PTNQ
$1.31B
| $9.33K | ﹤0.01% |
+170
| New | +$8.72K |
2023 Q1
0 quarters
|
|
5870
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$266M
| $9.19K | ﹤0.01% |
496
| – | – |
2022 Q4
1 quarter
|
|
5871
Invesco Large Cap Value ETF
PWV
$1.83B
| $9.04K | ﹤0.01% |
199
| – | – |
2021 Q4
5 quarters
|
|
5872
Global X ClimateTech ETF
CTEC
$25.1M
| $9.01K | ﹤0.01% |
+108
| New | +$8.54K |
2023 Q1
0 quarters
|
|
|
BZUN
5873
Baozun
BZUN
$194M
| $9K | ﹤0.01% |
1,535
-13,918
| -90% | -$91.8K |
2019 Q4
13 quarters
|
|
|
CSAN
5874
DELISTED
Cosan
CSAN
| $9K | ﹤0.01% |
775
| – | – |
2021 Q1
8 quarters
|
|
|
DOG
5875
ProShares Short Dow30
DOG
$109M
| $9K | ﹤0.01% |
260
| – | – |
2020 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.